A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma

• Published in: Molecular cancer Vol. 21; no. 1; pp. 93 - 16
• Main Authors: Duan, Jin-Ling, Chen, Wei, Xie, Juan-Juan, Zhang, Mao-Lei, Nie, Run-Cong, Liang, Hu, Mei, Jie, Han, Kai, Xiang, Zhi-Cheng, Wang, Feng-Wei, Teng, Kai, Chen, Ri-Xin, Deng, Min-Hua, Yin, Yi-Xin, Zhang, Nu, Xie, Dan, Cai, Mu-Yan
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02-04-2022; BioMed Central; BMC
• Subjects: Adenosine - analogs & derivatives; AIF; Antibodies; Apoptosis; Apoptosis-inducing factor; Cancer; Carcinoma, Hepatocellular - pathology; Chemoresistance; Chemotherapy; circMAP3K4; Cisplatin; Development and progression; Hepatocellular carcinoma; Hepatoma; Humans; Ligases; Liver cancer; Liver Neoplasms - pathology; MIB1; MicroRNAs; Mutation; N6-methyadenosine; N6-methyladenosine; Oncology, Experimental; Peptides; Prevention; Proteasomes; Translation; Ubiquitin; Ubiquitin-protein ligase; Hepatocellular carcinoma; Translation; circMAP3K4; AIF; N6-methyadenosine; MIB1
• ISSN: 1476-4598; 1476-4598
• DOI: 10.1186/s12943-022-01537-5

Circular RNAs (circRNAs) regulate various biological activities and have been shown to play crucial roles in hepatocellular carcinoma (HCC) progression. However, only a few coding circRNAs have been identified in cancers, and their roles in HCC remain elusive. This study aimed to identify coding circRNAs and explore their function in HCC.
CircMAP3K4 was selected from the CIRCpedia database. We performed a series of experiments to determine the characteristics and coding capacity of circMAP3K4. We then used in vivo and in vitro assays to investigate the biological function and mechanism of circMAP3K4 and its protein product, circMAP3K4-455aa, in HCC.
We found circMAP3K4 to be an upregulated circRNA with coding potential in HCC. IGF2BP1 recognized the circMAP3K4 N6-methyladenosine modification and promoted its translation into circMAP3K4-455aa. Functionally, circMAP3K4-455aa prevented cisplatin-induced apoptosis in HCC cells by interacting with AIF, thus protecting AIF from cleavage and decreasing its nuclear distribution. Moreover, circMAP3K4-455aa was degraded through the ubiquitin-proteasome E3 ligase MIB1 pathway. Clinically, a high level of circMAP3K4 is an independent prognostic factor for adverse overall survival and adverse disease-free survival of HCC patients.
CircMAP3K4 is a highly expressed circRNA in HCC. Driven by m6A modification, circMAP3K4 encoded circMAP3K4-455aa, protected HCC cells from cisplatin exposure, and predicted worse prognosis of HCC patients. Targeting circMAP3K4-455aa may provide a new therapeutic strategy for HCC patients, especially for those with chemoresistance. CircMAP3K4 is a highly expressed circRNA in HCC. Driven by m6A modification, IGF2BP1 facilitates circMAP3K4 peptide translation, then the circMAP3K4 peptide inhibits AIF cleavage and nuclear distribution, preventing HCC cells from cell death under stress and promoting HCC progression.